Suppr超能文献

程序性死亡蛋白1/程序性死亡配体1通路介导的髓源性抑制细胞在脓毒症诱导免疫抑制中的研究进展

[Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression].

作者信息

Xu Yifei, Zang Xuefeng, Chen Wei

机构信息

Department of Critical Care Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China. Corresponding author: Chen Wei, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Mar;36(3):332-336. doi: 10.3760/cma.j.cn121430-20231028-00918.

Abstract

Sepsis is a life-threatening organ dysfunction due to dysregulation of the body's response to infection. The immunosuppressive phase of sepsis is also an important cause of high morbidity and mortality in patients with advanced sepsis. Myeloid-derived suppressor cell (MDSC), as a heterogeneous population of Gr1CD11b immature cells, play a pivotal role in the immune process of advanced sepsis together with programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) with immunosuppressive properties. This review summarized the research progress of PD-1/PD-L1 pathway-mediated mechanism of MDSC in septic immunosuppression in recent years. The mechanism of action of PD-1/PD-L1 pathway in the immunosuppressive stage, the effects of PD-1/PD-L1 pathway on the "dual-signaling" model of MDSC through the signaling pathway and cytokines, as well as the time course of PD-1/PD-L1 pathway mediation in sepsis were described.

摘要

脓毒症是由于机体对感染的反应失调而导致的危及生命的器官功能障碍。脓毒症的免疫抑制阶段也是晚期脓毒症患者高发病率和高死亡率的重要原因。髓源性抑制细胞(MDSC)作为Gr1CD11b未成熟细胞的异质性群体,与具有免疫抑制特性的程序性死亡-1(PD-1)和程序性死亡配体-1(PD-L1)一起,在晚期脓毒症的免疫过程中起关键作用。本文综述了近年来PD-1/PD-L1通路介导的MDSC在脓毒症免疫抑制中的作用机制研究进展。描述了PD-1/PD-L1通路在免疫抑制阶段的作用机制、通过信号通路和细胞因子对MDSC“双信号”模型的影响,以及PD-1/PD-L1通路在脓毒症中介导作用的时间进程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验